Shalin Y. Shah

Shalin Shah serves as the Chief Executive Officer of Marius Pharmaceuticals, a company dedicated to innovative therapies for testosterone deficiency and its associated comorbidities. With a rich background in finance and investments, Shalin previously held roles as Co-Chief Executive Officer and CFO/EVP Strategy at Marius Pharmaceuticals and as Director of Private Investments at Shah Capital. Shalin began a career in investment as an Investment Executive at Barclays Ventures, focusing on mid-market private equity. Shalin holds a Bachelor of Science degree in Finance with a minor in Political Science from Rutgers University.